Clinical trial
PROcalcitonin Impact on Antibiotic Reduction, adverSe Events and AVoidable healthcarE Costs
NCT04158804 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PROcalcitonin Impact on Antibiotic Reduction, adverSe Events and AVoidable healthcarE Costs
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 28, 2020
- Completion date
- June 17, 2023
- Enrollment
- 700 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.